Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
JJ Pharma
AddedMar 20, 2024
UpdatedJun 18, 2026
JJ Pharma

JJ Pharma

Biotech company creating microbial therapies for health.

HQ
San Francisco, CA, US
Founded
2004
Overview
Compare
Fundraising
Employees

JJ Pharma is a biotechnology company dedicated to producing microbial fermentations for therapeutic applications. The company focuses on developing drug compounds for cardiovascular and arthritis diseases, cancer, and tuberculosis. Its key products include JJP-10 and JJP-11, which are water-soluble cholesterol-altering compounds, and JJP-12, a small molecule aimed at reducing arthritis symptoms.

JJ Pharma has made significant strides in the biotech field, particularly with its innovative microbial therapies. The company's products are designed to minimize liver and muscle toxicity and prevent drug interactions, showcasing their commitment to safer, more effective treatments.

JJ Pharma - Similar Companies

D&D Pharmatech logo

D&D Pharmatech

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

jazzpharma.com

JDP Therapeutics logo

JDP Therapeutics

JK BioPharma Solutions logo

JK BioPharma Solutions

Rjs Biologics logo

Rjs Biologics

J&J Solutions logo

J&J Solutions

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Pharmazz logo

Pharmazz

pharmazz.com

JB Therapeutics logo

JB Therapeutics

PIN Pharma logo

PIN Pharma

pinpharma.com

G2B Pharma logo

G2B Pharma

Jenken Biosciences logo

Jenken Biosciences

Cardeas Pharma logo

Cardeas Pharma

Gemmus Pharma logo

Gemmus Pharma

JJ Pharma - Quick Facts

Who are JJ Pharma's competitors?

Companies similar to JJ Pharma include D&D Pharmatech, Jazz Pharmaceuticals, JDP Therapeutics and JK BioPharma Solutions.

When was JJ Pharma founded?

JJ Pharma was founded in 2004.

Where is JJ Pharma's headquarters located?

JJ Pharma's headquarters is located in San Francisco, CA, US.

When was JJ Pharma's last funding round?

JJ Pharma's most recent funding round was for $255k (USD) in September 2009.

How much has JJ Pharma raised to-date?

As of Sep 5, 2009, JJ Pharma has raised a total of $255k (USD).

How many employees does JJ Pharma have?

JJ Pharma has 6 employees as of Feb 5, 2024.

JJ Pharma - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
  • Small Business
Main Product
  • Drug Development
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 12 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research